DE602005023772D1 - LNA OLIGONUCLEOTIDES AND CANCER TREATMENT - Google Patents

LNA OLIGONUCLEOTIDES AND CANCER TREATMENT

Info

Publication number: DE602005023772D1
Authority: DE; Germany
Prior art keywords: cancer treatment; lna oligonucleotides; lna; oligonucleotides; cancer
Prior art date: 2004-11-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE602005023772T

Other languages

German (de)

Inventor

Lene Soenderbye Kjarulff

Marlene Asklund

Majken Westergaard

Christoph Rosenbohm

Margit Wissenbach

Bo Hansen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Roche Innovation Center Copenhagen AS

Original Assignee

Santaris Pharma AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-09

Filing date

2005-11-09

Publication date

2010-11-04

2005-11-09 Application filed by Santaris Pharma AS filed Critical Santaris Pharma AS

2005-11-09 Priority claimed from PCT/DK2005/000719 external-priority patent/WO2006050732A2/en

2010-11-04 Publication of DE602005023772D1 publication Critical patent/DE602005023772D1/en

Status Active legal-status Critical Current

2025-11-10 Anticipated expiration legal-status Critical

Links

DE602005023772T 2004-11-09 2005-11-09 LNA OLIGONUCLEOTIDES AND CANCER TREATMENT Active DE602005023772D1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62656104P	2004-11-09	2004-11-09
DKPA200401728		2004-11-09
PCT/DK2005/000719 WO2006050732A2 (en)	2004-11-09	2005-11-09	Lna oligonucleotides and the treatment of cancer

Publications (1)

Publication Number	Publication Date
DE602005023772D1 true DE602005023772D1 (en)	2010-11-04

Family

ID=38965697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602005023772T Active DE602005023772D1 (en)	2004-11-09	2005-11-09	LNA OLIGONUCLEOTIDES AND CANCER TREATMENT

Country Status (6)

Country	Link
CN (1)	CN101065485B (en)
AT (1)	ATE482271T1 (en)
DE (1)	DE602005023772D1 (en)
DK (1)	DK1824975T3 (en)
ES (1)	ES2353638T3 (en)
ZA (1)	ZA200704254B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20110294870A1 (en) *	2008-12-04	2011-12-01	Opko Curna, Llc	Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ514348A (en) *	1999-05-04	2004-05-28	Exiqon As	L-ribo-LNA analogues
AU2003229930A1 (en) *	2002-04-24	2003-11-10	University Of Bern	A role for survivin in apoptosis of myeloid cells
AU2004209598B2 (en) *	2003-02-10	2009-08-06	Enzon Pharmaceuticals, Inc.	Oligomeric compounds for the modulation of survivin expression

2005
- 2005-11-09 ZA ZA200704254A patent/ZA200704254B/en unknown
- 2005-11-09 DE DE602005023772T patent/DE602005023772D1/en active Active
- 2005-11-09 ES ES05800759T patent/ES2353638T3/en active Active
- 2005-11-09 DK DK05800759.2T patent/DK1824975T3/en active
- 2005-11-09 CN CN2005800409084A patent/CN101065485B/en not_active Expired - Fee Related
- 2005-11-09 AT AT05800759T patent/ATE482271T1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN101065485B (en)	2011-12-07
ES2353638T9 (en)	2011-06-16
ES2353638T3 (en)	2011-03-03
ATE482271T1 (en)	2010-10-15
ZA200704254B (en)	2009-09-30
DK1824975T3 (en)	2011-06-06
CN101065485A (en)	2007-10-31

Similar Documents

Publication	Publication Date	Title
IL178012A0 (en)	2006-12-31	Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL188746A0 (en)	2008-08-07	Treatment of cancer
EP1814544A4 (en)	2009-12-02	Cancer treatments
NO20070251A (en)	2007-03-12	Well treatment
EP1814909A4 (en)	2008-06-25	Use of aimp2dx2 for the diagnosis and treatment of cancer
EP1816953A4 (en)	2010-03-31	Cancer detection and treatment instrument
EP1968607A4 (en)	2010-07-07	Treatment of cancer and other diseases
NO20070297A (en)	2007-03-12	Well treatment
CY2200156T2 (en)	2010-07-28	WASTEWATER TREATMENT
DK1863899T3 (en)	2013-10-14	skin treatment
EP1756166A4 (en)	2008-08-27	Prostate cancer diagnosis and treatment
EP1830847A4 (en)	2012-09-12	Treatment for cancer
HK1117780A1 (en)	2009-01-23	Compounds and methods for the treatment of cancer
DE602005010556D1 (en)	2008-12-04	HYBRIDIZATION PROCESSES AND HYBRIDIZATION MICROARRAY AND HYBRIDIZATION KIT
GB0428187D0 (en)	2005-01-26	Cancer treatment
GB0413346D0 (en)	2004-07-21	Treating cancer
GB0520067D0 (en)	2005-11-09	Treatment of cancer
DE602005023772D1 (en)	2010-11-04	LNA OLIGONUCLEOTIDES AND CANCER TREATMENT
GB0701549D0 (en)	2007-03-07	Skin treatment
GB0507685D0 (en)	2005-05-25	Cancer treatment
GB0404675D0 (en)	2004-04-07	Cancer treatment
EP1907855A4 (en)	2009-11-11	Genetic and epigenetic alterations in the diagnosis and treatment of cancer
GB0423830D0 (en)	2004-12-01	Skin treatment device
ATE439424T1 (en)	2009-08-15	TREATMENT PRODUCT AND TREATMENT PROCEDURE
GB0410379D0 (en)	2004-06-16	Treatment of cancer